These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 3000292)

  • 1. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Wolfson JS; Hooper DC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):581-6. PubMed ID: 3000292
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinolones: pharmacology.
    Verbist L
    Pharm Weekbl Sci; 1986 Feb; 8(1):22-5. PubMed ID: 3008075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluoroquinolones. 1. Their chemical structure, mechanism of action and antibacterial activity].
    Stahlmann R; Kemmerich B; Lode H
    Dtsch Med Wochenschr; 1988 Apr; 113(16):648-51. PubMed ID: 2834166
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action of quinolones].
    Smith JT
    Infection; 1986; 14 Suppl 1():S3-15. PubMed ID: 2420724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action, and in vitro and in vivo activities of the fluoroquinolones.
    Fernandes PB
    J Clin Pharmacol; 1988 Feb; 28(2):156-68. PubMed ID: 3283179
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative in vitro activity of the new quinolone CI-934.
    Verbist L
    Eur J Clin Microbiol; 1986 Jun; 5(3):343-5. PubMed ID: 2943590
    [No Abstract]   [Full Text] [Related]  

  • 8. Computer automated structure evaluation of quinolone antibacterial agents.
    Klopman G; Macina OT; Levinson ME; Rosenkranz HS
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1831-40. PubMed ID: 2829716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.
    Hirschhorn L; Neu HC
    Antimicrob Agents Chemother; 1986 Jul; 30(1):143-6. PubMed ID: 3752975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthetic chemotherapeutic agents V. Antibacterial activities of thiazolo[5,4-f]quinolinecarboxylic acid derivatives (author's transl)].
    Kadoya S; Nagasaki S
    Yakugaku Zasshi; 1979 May; 99(5):483-92. PubMed ID: 544775
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro activity and resistance of 4-quinolones].
    Bauernfeind A
    Infection; 1986; 14 Suppl 3():S186-7. PubMed ID: 3531027
    [No Abstract]   [Full Text] [Related]  

  • 13. Enantiomers of 1-ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid: preparation and biological activity.
    Culbertson TP; Domagala JM; Nichols JB; Priebe S; Skeean RW
    J Med Chem; 1987 Oct; 30(10):1711-5. PubMed ID: 2821256
    [No Abstract]   [Full Text] [Related]  

  • 14. The quinolones and dermatologic practice.
    Parish LC; Witkowski JA
    Int J Dermatol; 1986; 25(6):351-6. PubMed ID: 3531041
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics.
    Jack DB
    J Clin Hosp Pharm; 1986 Apr; 11(2):75-93. PubMed ID: 3519688
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
    Chin NX; Figueredo VM; Novelli A; Neu HC
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.
    Cometta A; Marchetti O; Calandra T; Bille J; Kern WV; Zinner S;
    Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):537-40. PubMed ID: 16896825
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of substituted quinoline-3-carbaldehyde (2,3-dihydrothiazol-2-ylidene) hydrazones of potential antimicrobial activity.
    Farghally AM; Habib NS; Hazzaa AA; el-Sayed OA
    J Pharm Belg; 1985; 40(6):366-72. PubMed ID: 3831291
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ; Brickner SJ; Hamel JC; Brennan L; Casavant JM; Chen M; Chen T; Ding X; Driscoll J; Hardink J; Hoang T; Hua E; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Plotkin M; Reilly U; Robinson S; Schafer J; Shepard RM; Smith JF; Stone GG; Subramanyam C; Yoon K; Yuan W; Zaniewski RP; Zook C
    Bioorg Med Chem Lett; 2013 May; 23(10):2955-61. PubMed ID: 23566517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.
    Janknegt R
    Pharm Weekbl Sci; 1986 Feb; 8(1):1-21. PubMed ID: 3515312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.